Cutera (CUTR) to Release Quarterly Earnings on Thursday

Cutera (NASDAQ:CUTRGet Free Report) will be issuing its quarterly earnings data after the market closes on Thursday, March 21st. Analysts expect the company to announce earnings of ($0.87) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Cutera (NASDAQ:CUTRGet Free Report) last issued its quarterly earnings results on Tuesday, March 5th. The medical device company reported ($2.22) EPS for the quarter. The firm had revenue of $46.48 million for the quarter. On average, analysts expect Cutera to post $-4 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Cutera Stock Down 8.0 %

Shares of Cutera stock opened at $1.83 on Tuesday. The firm has a market cap of $36.49 million, a P/E ratio of -0.33 and a beta of 1.70. Cutera has a fifty-two week low of $1.38 and a fifty-two week high of $27.58. The business has a 50-day moving average price of $2.72 and a 200 day moving average price of $3.78.

Wall Street Analysts Forecast Growth

Separately, Stephens reissued an “overweight” rating and set a $10.00 target price on shares of Cutera in a report on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $14.75.

Read Our Latest Report on CUTR

Institutional Investors Weigh In On Cutera

Large investors have recently added to or reduced their stakes in the stock. Captrust Financial Advisors increased its stake in shares of Cutera by 592.2% in the first quarter. Captrust Financial Advisors now owns 533 shares of the medical device company’s stock valued at $37,000 after purchasing an additional 456 shares during the period. Almanack Investment Partners LLC. acquired a new position in shares of Cutera during the third quarter valued at approximately $25,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Cutera by 69.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,348 shares of the medical device company’s stock valued at $88,000 after purchasing an additional 966 shares during the period. Ensign Peak Advisors Inc acquired a new position in shares of Cutera during the 3rd quarter valued at $131,000. Finally, Point72 Middle East FZE acquired a new position in shares of Cutera during the 4th quarter valued at $137,000.

About Cutera

(Get Free Report)

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform.

See Also

Earnings History for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.